Oxaliplatin, fluorouracil, and leucovorin with or without cetuximab in patients with resected stage III colon cancer (PETACC-8): an open-label, randomised phase 3 trial

Since the 1990s, fluorouracil-based adjuvant chemotherapy has significantly reduced the risk of tumour recurrence in patients with stage III colon cancer. We aimed to assess whether the addition of cetuximab to standard adjuvant oxaliplatin, fluorouracil, and leucovorin chemotherapy (FOLFOX4) in pat...

Full description

Saved in:
Bibliographic Details
Published in:The lancet oncology Vol. 15; no. 8; pp. 862 - 873
Main Authors: Taieb, Julien, Tabernero, Josep, Mini, Enrico, Subtil, Fabien, Folprecht, Gunnar, Van Laethem, Jean-Luc, Thaler, Josef, Bridgewater, John, Petersen, Lone Nørgård, Blons, Hélène, Collette, Laurence, Van Cutsem, Eric, Rougier, Philippe, Salazar, Ramon, Bedenne, Laurent, Emile, Jean-François, Laurent-Puig, Pierre, Lepage, Come
Format: Journal Article
Language:English
Published: England Elsevier Ltd 01.07.2014
Elsevier Limited
Elsevier
Subjects:
ISSN:1470-2045, 1474-5488, 1474-5488
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first